Profound Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	24.83	54.91	26.21	46.52	67.15	83.91
Cash & Short-Term Investments	24.83	54.91	26.21	46.52	67.15	83.91
Cash Growth	-8.47%	109.48%	-43.65%	-30.73%	-19.97%	466.98%
Accounts Receivable	7.31	6.43	6.75	5.84	1.41	6.45
Other Receivables	0.86	0.62	0.53	0.51	-	0.99
Receivables	8.17	7.05	7.29	6.34	1.41	7.43
Inventory	8.34	5.8	6.99	7.94	7.41	5.33
Prepaid Expenses	0.2	1.31	1.41	1.22	1.15	1.07
Total Current Assets	41.52	69.07	41.9	62.02	77.13	97.74
Property, Plant & Equipment	0.58	0.82	1.57	1.72	1.9	2.28
Goodwill	-	-	-	-	2.69	2.68
Other Intangible Assets	0.12	0.26	0.49	0.68	1.44	1.9
Long-Term Accounts Receivable	-	-	-	-	3.62	-
Long-Term Deferred Tax Assets	0.08	0.09	-	-	-	-
Total Assets	42.31	70.23	43.96	64.42	86.78	104.6
Accounts Payable	0.72	1.32	0.87	2.03	3.18	3.38
Accrued Expenses	3.97	2.84	2.42	-	-	-
Current Portion of Long-Term Debt	4.48	1.74	2.1	0.52	-	-
Current Portion of Leases	0.28	0.26	0.26	0.24	0.25	0.31
Current Income Taxes Payable	0.06	-	-	0.3	-	0.01
Current Unearned Revenue	0.43	0.42	0.72	0.47	0.48	0.36
Other Current Liabilities	-	-	-	0.62	0.25	0.74
Total Current Liabilities	9.94	6.57	6.37	4.18	4.16	4.81
Long-Term Debt	-	2.92	5	6.65	-	-
Long-Term Leases	-	0.2	0.5	0.82	1.13	1.36
Long-Term Unearned Revenue	0.15	0.05	0.73	0.76	0.88	1.08
Long-Term Deferred Tax Liabilities	-	-	0.06	-	-	-
Other Long-Term Liabilities	0.08	0.07	0.07	-	-	-
Total Liabilities	10.16	9.81	12.73	12.42	6.16	7.25
Common Stock	282.75	281.55	222.21	205.83	219.58	211.53
Additional Paid-In Capital	24.21	21.3	20.81	18.7	16.99	11.25
Retained Earnings	-279.57	-245.17	-217.35	-189.36	-160.69	-129.99
Comprehensive Income & Other	4.75	2.74	5.57	16.84	4.75	4.57
Shareholders' Equity	32.14	60.42	31.22	52	80.62	97.35
Total Liabilities & Equity	42.31	70.23	43.96	64.42	86.78	104.6
Total Debt	4.76	5.12	7.87	8.23	1.38	1.68
Net Cash (Debt)	20.07	49.79	18.35	38.29	65.78	82.24
Net Cash Growth	-3.95%	171.40%	-52.08%	-41.79%	-20.02%	2047.74%
Net Cash Per Share	0.69	2.01	0.87	1.84	3.21	4.76
Filing Date Shares Outstanding	30.19	30.04	24.43	20.91	20.78	20.29
Total Common Shares Outstanding	30.19	30.04	21.37	20.88	20.78	20.21
Working Capital	31.59	62.5	35.53	57.84	72.97	92.93
Book Value Per Share	1.06	2.01	1.46	2.49	3.88	4.82
Tangible Book Value	32.02	60.16	30.73	51.32	76.49	92.77
Tangible Book Value Per Share	1.06	2.00	1.44	2.46	3.68	4.59
Machinery	1.41	2.27	2.58	0.54	1.2	1.83
Leasehold Improvements	0.54	0.54	0.54	1.84	0.58	0.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q